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 ABSTRACT | Saliva is important for the preservation and maintenance of normal physiological conditions of oral tissues, and factors 
influencing its decrease are associated with the risk for oral diseases. Xerostomia is the subjective sensation of oral 
dryness, which can be influenced by etiological factors including the use of several types of medications, Sjogren’s and 
metabolic syndromes, head and neck irradiation, among others. Treatment methods for xerostomia vary and can be lo-
cal or systemic. The aim of this article is to present the results of a literature review addressing the correlation between 
xerostomia and its incidence and prevalence in the older adult population. Results of this review highlight the impor-
tance of diagnosis and appropriate management, and briefly describe treatment modalities and etiological factors such 
as medications, Sjogren’s syndrome, metabolic syndrome, and head and neck irradiation.
 DESCRIPTORS | Xerostomia; Dry mouth; Saliva.
 RESUMO | Xerostomia na população idosa, do diagnóstico ao tratamento: revisão da literatura • A saliva é importante para a preservação 
e manutenção das condições fisiológicas normais dos tecidos bucais, e os fatores que influenciam sua diminuição estão associados ao 
risco de doenças bucais. Xerostomia é a sensação subjetiva de secura oral, que pode ser influenciada por fatores etiológicos, incluindo o 
uso de vários tipos de medicamentos, síndromes metabólicas e de Sjögren, irradiação de cabeça e pescoço, entre outros. Os métodos de 
tratamento para xerostomia variam e podem ser locais ou sistêmicos. O objetivo deste artigo é apresentar os resultados de uma revisão 
bibliográfica abordando a correlação entre xerostomia e sua incidência e prevalência na população idosa. Os resultados desta revisão 
destacam a importância do diagnóstico e do manejo adequado e descrevem brevemente as modalidades de tratamento e fatores etiológi-
cos, como medicamentos, síndrome de Sjögren, síndrome metabólica e irradiação de cabeça e pescoço.
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INTRODUCTION 
Xerostomia is characterized as the subjective 
sensation of dry mouth, whereas hyposalivation 
describes a reduction in salivary flow. Xerostomia, 
however, does not necessarily imply in a decrease 
in salivary flow because patients who do not exhibit 
hyposalivation may exhibit xerostomia.1
Salivary function remains remarkably intact in 
healthy older adults; however, numerous etiological 
factors can induce and/or maintain xerostomia, 
including dehydration, mouth breathing, hormonal 
changes, autoimmune diseases – e.g., Sjogren’s 
syndrome –, chronic mouth breathing caused by 
disease, head and neck irradiation, diseases such as 
diabetes mellitus, nephritis, thyroid dysfunction, 
HIV infection, kidney diseases, and continuous 
use of numerous medications. The latter seems to 
be the most common cause of xerostomia in older 
adults because most are treated with at least one 
medication that causes salivary hypofunction.2
Xerostomia is not directly associated with 
the normal aging process in older adults but 
as a consequence of disease, or as a side effect 
of medication(s).1,3 Approximately 30% of the 
population ≥ 65 years of age experience some type 
of dry mouth-related disorder.1
The objective of this study was to perform a 
review of the literature addressing xerostomia 
to demonstrate the importance of diagnosis and 
appropriate management, and to describe applicable 
treatment modalities.
MATERIALS AND METHODS 
A bibliographic search of the scientific literature 
indexed in the PubMed and Google Scholar 
databases was performed using the keywords 
“Xerostomia”, “Dry mouth”, “Saliva”, and “Elderly”. 
Articles published in Portuguese and/or English, 
available in full-text, and published in the past 15 
years were included. After screening, 26 articles 
were selected.
Literature review 
Xerostomia and hyposalivation 
The term “xerostomia” is related to several 
concepts and often correlated with decreased 
salivary flow or simply the subjective sensation of dry 
mouth, thus causing confusion regarding the term.4 
Xerostomia may result from decreased or altered 
salivary gland function, with changes in salivary 
quality/quantity.4 Hyposalivation, with or without 
the sensation of dry mouth, can result from several 
causes, although its main etiological factors are the 
inhibition of salivation reflex and alterations in the 
salivary glands.5
Prevalence of xerostomia 
Studies addressing the prevalence of xerostomia 
in diverse populations have reported significant 
variability, possibly due to the different definitions 
and instruments used to measure it. As such, 
prevalence varies from 10% to 46%, with a lower 
prevalence in men (9.7-25.8%) than in women 
(10.3-33.3%).6 A recent systematic review suggests 
a prevalence of approximately 20%, although 
this figure appears to be higher in older and 
institutionalized populations.7
It is generally accepted that aging alone has no 
significant clinical impact on salivary flow; however, 
the prevalence of xerostomia appears to increase 
with age, affecting mainly middle-aged and older 
individuals,8 which can be explained by the greater 
number of drugs used by these populations.
Etiological factors of xerostomia 
Medication
Although aging does not correlate with a higher 
prevalence of xerostomia, its occurrence may be 
the result of certain types of drugs used by older 
populations or the combination of many drugs (i.e., 
polypharmacy).7 Several studies3,6,9 have reported 
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that groups of drugs, such as antidepressants, 
anticholinergics, antihistamines, and anxiolytics 
and antihypertensives, may largely explain the 
prevalence of xerostomia.
Sjogren’s syndrome 
Sjogren’s syndrome is a systemic autoimmune 
disease that generates chronic inflammation of the 
exocrine glands and usually affects the salivary and 
lacrimal glands,9 leading to dryness of the major 
mucosal surfaces including the mouth, eyes, nose, 
pharynx, larynx, and vagina.8
The etiology of Sjogren’s syndrome appears 
to have a genetic and environmental basis. The 
disease affects mostly middle-aged women but can 
also affect children, men, and older adults. When 
symptoms of dryness appear in a previously healthy 
individual, the syndrome is classified as primary 
Sjogren’s syndrome. Sjogren’s syndrome associated 
with other underlying systemic autoimmune 
diseases – e.g., systemic lupus erythematosus, 
rheumatoid arthritis or scleroderma – is known as 
secondary Sjogren’s syndrome.10
Metabolic syndrome 
Metabolic syndrome has received worldwide 
attention in recent years due to its increasing 
prevalence (20% to 30%) in the adult population 
of virtually all Western countries, and has grown 
in parallel with obesity.11 This syndrome is 
characterized as a group of related diseases, including 
hyperglycemia, obesity, hypertension, dyslipidemia, 
diabetes mellitus and cardiovascular disease, all of 
which are related to insulin resistance.1
Salivary pH and flow rate are affected by several 
components of the metabolic syndrome.1
Head and neck irradiation 
Salivary tissue is highly vulnerable to radiation 
damage, and the parotid glands are the most easily 
damaged. Radiation doses as low as 20 Gray (Gy) 
may cause permanent discontinuation of salivary 
flow if applied in a single dose. Salivary dysfunction 
is severe at > 52 Gy doses. Oral cancer treatment 
usually involves the administration of 60 Gy and 
70 Gy doses, which may lead to a rapid decrease 
in flow during the first week of radiation, with a 
possible 95% reduction in the region. After 5 weeks 
of radiation, salivary flow virtually ceases and rarely 
recovers completely, and stimulated and resting 
salivary flow is inhibited. The degree of xerostomia 
depends on the degree of salivary tissue exposed to 
radiation, with partially irradiated glands exhibiting 
greater salivary flow than fully irradiated glands.8
Radioiodine treatment has been used to treat 
thyroid cancer for > 70 years. One of its main 
complications is xerostomia, which is caused by 
radiation damage to the salivary glands. Xerostomia 
rates in these patients are high, ranging from 42.9% 
to 54%.12
Xerostomia in these patients can lead to an 
increased susceptibility to dental caries, a higher 
tendency to develop opportunistic fungal infections 
(Candida albicans), and loss of denture retention.13
Other conditions 
Dehydration due to reduced fluid intake, vomiting, 
and diarrhea may result in xerostomia. Dry mouth 
is also a common complaint in patients with 
diabetes mellitus. Psychogenic causes – e.g., fear, 
stress, depression and anxiety – can also result in 
xerostomia. In cases of Alzheimer’s disease or stroke, 
patients may complain of dry mouth in the presence of 
normal salivary secretion due to altered perception.14
Treatment 
The first step in treating patients with xerostomia 
is to establish a correct diagnosis. This often involves 
a multidisciplinary team of health professionals, 
among whom communication is essential because 
many older individuals have concomitant medical 
problems and polypharmacy complications. The 
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second step is to schedule frequent dental evaluations 
of patients at risk of oral complications due to low 
salivary flow.6
The surfaces of dried mucous membranes and 
dysphagia are treated with oral moisturizers and 
lubricants, artificial saliva, and the nocturnal use 
of bedside humidifiers. Clinicians should instruct 
patients to drink liquids while eating, especially if 
the food is dry and/or rough in texture.2,4,15,16
Local treatment 
Numerous saliva substitutes and topical 
agents – e.g., sugar-free gums and lozenges – are 
currently available and have been shown to provide 
relief of xerostomia by improving lubrication 
and hydration of oral tissues. The first goal is 
to physiologically increase salivary secretion to 
improve patient quality of life and, if not, then by 
artificial means.10
Symptomatic relief such as drinking water 
throughout the day or holding pieces of ice in the 
mouth to provide moisture can be sufficient to 
relieve symptoms. Other measures include sucking 
on pineapple slices, frequent sips of orange juice 
or semi-frozen fruit juice, or the use of sugar-free 
chewing gum. Patients may use olive oil and some 
dry-mouth products containing olive oil, with 
effective benefits for xerostomia.17
Salivary stimulation tablets provide subjective 
relief of dry mouth, improving the quality of life 
in patients with radiation-induced xerostomia.15 
Saliva substitutes consist mainly of aqueous 
solutions containing the same mineral salts as 
those found in human saliva, thus mimicking 
the natural functions of these elements within 
the oral cavity. Artificial saliva usually contains 
enzymes with antimicrobial action or mucins as 
lubricants. These formulations sometimes contain 
elements that add extra protection to avoid excess 
bacterial colonization of oral tissues and, in turn, 
the development of dental caries.18
However, the viscosity, surface tension, and 
adsorption/desorption of salivary substitutes 
significantly differ from saliva and may limit the 
duration and/or extent of their effects.19
Cholinergic agonists 
Muscarinic receptor agonists M3 (pilocarpine 
and cevimeline) administered orally are used to 
increase salivary secretion. Systemic pilocarpine has 
been discovered as an effective means of treating 
xerostomia secondary to head and neck radiation. 
More recently, this medication was found to have a 
potential benefit in patients with Sjogren’s syndrome, 
especially in those with symptomatic extraoral 
exocrinopathy.15
Clinical experience to date suggests that 
pilocarpine is safe and well tolerated, with no serious 
adverse effects or tachyphylaxis.8
Electrostimulation 
Neural electrostimulation of salivary gland 
function by application of electrical current through 
the oral mucosa in receptors in the afferent nerve 
pathways has been reported to increase saliva 
production and reduce the symptoms of xerostomia 
induced by various conditions.8
More recently, the use of extra-oral transcutaneous 
electrical nerve stimulation (TENS) on the parotid 
gland has been reported to effectively increase 
salivary production in healthy individuals, suggesting 
that TENS can directly stimulate the auriculotemporal 
nerve, which innervates the secretory unit of the 
parotid gland.8,20
Acupuncture 
Acupuncture is a traditional Chinese medicine 
technique used to treat various pathologies in a 
palliative or curative manner and is recognized by 
the World Health Organization.1
The mechanisms of increasing the salivary flow 
rate in patients with xerostomia involves several 
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related factors, including increased local blood flow, 
the release of neuropeptides, and reflex mechanisms 
that promote parasympathetic stimulation. Results 
from studies involving patients with xerostomia 
have suggested that acupuncture may induce a 
prolonged increase in salivary flow rates. Several 
studies have confirmed the beneficial effects of 
acupuncture in the treatment of xerostomia caused 
by several diseases such as Sjogren’s syndrome, 
head and neck radiotherapy, hypothyroidism, or 
idiopathic causes.21-23
Laser 
Studies have shown that cancer patients 
undergoing laser phototherapy (1.5 J/cm2, 60 MW) 
to treat oral mucositis reported an improvement 
in saliva production and swallowing capacity. 
Stimulation of the salivary glands and improvement 
of xerostomia symptoms in a patient with Sjogren’s 
syndrome was also observed.24,25
DISCUSSION 
Xerostomia is a symptom that mainly affects 
the older adult population.1-4,26,27 Women are more 
affected than men,20 with approximately one-third 
of those ≥ 65 years of age experiencing symptoms of 
xerostomia.1 The xerostomia diagnosis has become 
increasingly frequent due to the growth of the older 
adult population both in Brazil and worldwide, given 
general increases in life expectancy.15
Saliva is essential in maintaining the health of the 
entire stomatognathic complex, having lubricating 
properties that facilitate the formation of the food 
bolus, in chewing, swallowing, and phonetics and 
phonation. Aside from the maintenance of oral pH 
(with its buffering action, which is active in the 
remineralization/demineralization process), saliva 
also plays a role in physical/chemical phenomena 
that act in the retention and stability of prostheses, 
has also having bactericidal, antiviral, and 
antifungal activity.6
According to Turner et al.,2 the most common 
cause of xerostomia is the use of various prescription 
and/or non-prescription medications. Several 
authors have cited drugs associated with the 
prevalence of xerostomia such as antidepressants, 
anticholinergics, antihistamines, anxiolytics, and 
antihypertensives.2,3,6,9
Sjogren’s syndrome is characterized as an 
autoimmune disease in which patients experience 
dysfunction of the secretory glands, with several 
systemic alterations, including dryness of the mucous 
membranes (oral, nasal, vaginal) or dry eyes (due 
to decreased flow lacrimal). Metabolic syndrome 
is also important and related to multiple systemic 
diseases, e.g., vascular diseases, diabetes mellitus, 
and dyslipidemia. The decrease in salivary flow rate in 
individuals with metabolic syndrome is related to the 
destruction of the acinar cells of the salivary glands.8,9
Head and neck irradiation is another factor 
that leads to the symptomatology of xerostomia via 
the destruction of the salivary glands exposed to 
radiation therapy.24,25
Strategies for the treatment of xerostomia 
symptomatology include palliative measures that 
can be local or systemic. The primary objective is 
to physiologically stimulate the patient’s salivary 
flow and, secondarily, by artificial means.8 Various 
treatment modalities have been described in 
the literature, ranging from mouthwashes with 
filtered water to low-power laser therapy and 
acupuncture.18,24,25
There are numerous options for local treatment 
methods, including the use of artificial saliva with 
mouthwash; sugarless gums that stimulate salivary 
flow by masticatory activity; salivary stimulation 
tablets; and moisturizers and oral lubricants.15 
Dietary guidance (low sucrose), with strict control 
of oral hygiene is crucial to prevent and treat the 
eventual oral consequences of xerostomia.18
For systemic treatment, options include agonist 
drugs of the muscarinic receptor M3, pilocarpine and 
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cevimeline. They act similarly to acetylcholine at M3 
receptors, stimulating the parasympathetic branch 
of the autonomic nervous system and increasing 
secretion from the exocrine glands, which in turn 
stimulate salivary flow.4
Xerostomia is a symptom with significant impact 
on oral health that can lead to the worsening of oral 
prosthesis retention, to increases in the incidence 
of caries, oral candidiasis, and in the incidence 
and severity of periodontal diseases, oral tissue 
dehydration, dryness of the lips; moreover, increase 
in the presence and extension of saburral tongue, 
halitosis, mucositis, and oral burning sensation 
may occur. Lingual fissures, dysgeusia, dysphagia, 
problems in phonation, chewing, and swallowing can 
also occur due to xerostomia.1-4,6,9,10,15,16,18,28
FINAL CONSIDERATIONS 
1) Xerostomia is a symptom that mainly affects 
the older adult population, with significant negative 
impact on oral health. The use of medication(s) is its 
primary etiological factor.
2) Multidisciplinary treatment is essential to 
diagnose and treat the inherent complications of 
xerostomia and provide a better quality of life to 
patients. There are local and systemic treatments, 
and many studies reported improvements in 
symptomatology.
3) Dental follow-up is necessary, both for 
symptomatology and its consequences. Therefore, 
the role of the dental surgeon is crucial in the 
diagnosis and treatment of this symptom.
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